{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:55:57Z","timestamp":1790240157486,"version":"4.1.0"},"reference-count":29,"publisher":"Hindawi Limited","issue":"5","license":[{"start":{"date-parts":[[2015,6,7]],"date-time":"2015-06-07T00:00:00Z","timestamp":1433635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,6,7]],"date-time":"2015-06-07T00:00:00Z","timestamp":1433635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1111\/jcpt.12297","type":"journal-article","created":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T00:12:56Z","timestamp":1433981576000},"page":"496-503","source":"Crossref","is-referenced-by-count":44,"title":["Systematic review of topical amitriptyline for the treatment of neuropathic pain"],"prefix":"10.1155","volume":"40","author":[{"given":"D. F.","family":"Thompson","sequence":"first","affiliation":[{"name":"College of Pharmacy; Southwestern Oklahoma State University; Weatherford OK USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. G.","family":"Brooks","sequence":"additional","affiliation":[{"name":"College of Pharmacy; Southwestern Oklahoma State University; Weatherford OK USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2015,6,7]]},"reference":[{"issue":"Suppl 1","key":"10.1111\/jcpt.12297-BIB0001|jcpt12297-cit-0001","first-page":"S3","article-title":"The epidemiology of pain in depression","volume":"19","author":"Levine","year":"2004","journal-title":"Hum Psychopharmacol"},{"key":"10.1111\/jcpt.12297-BIB0002|jcpt12297-cit-0002","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1526-4637.2009.00588.x","article-title":"The prevalence of neuropathic pain: clinical evaluation compared with screening tools in a community population","volume":"10","author":"Yawn","year":"2009","journal-title":"Pain Med"},{"key":"10.1111\/jcpt.12297-BIB0003|jcpt12297-cit-0003","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"key":"10.1111\/jcpt.12297-BIB0004|jcpt12297-cit-0004","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7326\/M14-0511","article-title":"Pharmacologic interventions for painful diabetic neuropathy. An umbrella systematic review and comparative effectiveness network meta-analysis","volume":"161","author":"Griebeler","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1111\/jcpt.12297-BIB0005|jcpt12297-cit-0005","first-page":"41","volume-title":"Neuropathic pain - pharmacological management","author":"National Institute for Health and Care Excellence (NICE)","year":"2013"},{"key":"10.1111\/jcpt.12297-BIB0006|jcpt12297-cit-0006","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1082-3174(11)80029-2","article-title":"Thirteen consecutive well-designed randomized trials show that antidepressants reduce pain in diabetic neuropathy and postherpetic neuralgia","volume":"4","author":"Max","year":"1995","journal-title":"Pain Forum"},{"key":"10.1111\/jcpt.12297-BIB0007|jcpt12297-cit-0007","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/187152409787601932","article-title":"Mechanism and treatment of neuropathic pain","volume":"9","author":"Vranken","year":"2009","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"10.1111\/jcpt.12297-BIB0008|jcpt12297-cit-0008","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5214\/ans.0972.7531.1118409","article-title":"Painful diabetic neuropathy: an update","volume":"18","author":"Kaur","year":"2011","journal-title":"Ann Neurosci"},{"key":"10.1111\/jcpt.12297-BIB0009|jcpt12297-cit-0009","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/clpt.2011.115","article-title":"Chemotherapy-induced peripheral neuropathy: prevention and treatment","volume":"90","author":"Pachman","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12297-BIB0010|jcpt12297-cit-0010","first-page":"289","article-title":"Topical amitriptyline in healthy volunteers","volume":"28","author":"Gerner","year":"2003","journal-title":"Reg Anesth Pain Med"},{"key":"10.1111\/jcpt.12297-BIB0011|jcpt12297-cit-0011","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/AJP.0b013e318285d1ba","article-title":"Topical treatment of neuropathic pain using compounded medications","volume":"30","author":"Zur","year":"2014","journal-title":"Clin J Pain"},{"key":"10.1111\/jcpt.12297-BIB0012|jcpt12297-cit-0012","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1111\/jcpt.12297-BIB0013|jcpt12297-cit-0013","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1161\/01.CIR.0000063682.20730.A5","article-title":"American College of Cardiology\/American Heart Association clinical practice guidelines, part I","volume":"107","author":"Gibbons","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/jcpt.12297-BIB0014|jcpt12297-cit-0014","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00002508-200309000-00007","article-title":"A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain","volume":"19","author":"Lynch","year":"2003","journal-title":"Clin J Pain"},{"key":"10.1111\/jcpt.12297-BIB0015|jcpt12297-cit-0015","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00000542-200507000-00021","article-title":"Topical 2% Amitriptyline and 1% Ketamine in Neuropathic Pain Syndromes","volume":"103","author":"Lynch","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1111\/jcpt.12297-BIB0016|jcpt12297-cit-0016","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/AJP.0b013e318156db26","article-title":"Topical amitriptyline versus lidocaine in the treatment of neuropathic pain","volume":"24","author":"Ho","year":"2008","journal-title":"Clin J Pain"},{"key":"10.1111\/jcpt.12297-BIB0017|jcpt12297-cit-0017","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00520-010-0911-0","article-title":"A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA","volume":"19","author":"Barton","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1111\/jcpt.12297-BIB0018|jcpt12297-cit-0018","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s00520-014-2158-7","article-title":"A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors","volume":"22","author":"Gewandter","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1111\/jcpt.12297-BIB0019|jcpt12297-cit-0019","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jpain.2005.04.008","article-title":"Topical amitripyline and ketamine in neuropathic pain syndromes: an open-label study","volume":"6","author":"Lynch","year":"2005","journal-title":"J Pain"},{"key":"10.1111\/jcpt.12297-BIB0020|jcpt12297-cit-0020","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00520-011-1240-7","article-title":"Topical amitriptyline, ketamine, and lidocaine in neuropathic pain caused by radiation skin reaction: a pilot study","volume":"20","author":"Uzaraga","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1111\/jcpt.12297-BIB0021|jcpt12297-cit-0021","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1533-2500.2011.00477.x","article-title":"High doses of topical amitriptyline in neuropathic pain: two cases and literature review","volume":"12","author":"Kopsky","year":"2011","journal-title":"Pain Pract"},{"key":"10.1111\/jcpt.12297-BIB0022|jcpt12297-cit-0022","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.jpainsymman.2011.01.003","article-title":"Topical amitriptyline in post-traumatic neuropathic pain","volume":"41","author":"Liebregts","year":"2011","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/jcpt.12297-BIB0023|jcpt12297-cit-0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/319750","article-title":"Multimodal stepped care approach involving topical analgesics for severe intractable neuropathic pain in CRPS type 1: a case report","volume":"2011","author":"Kopsky","year":"2011","journal-title":"Case Rep Med"},{"key":"10.1111\/jcpt.12297-BIB0024|jcpt12297-cit-0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/471835","article-title":"Central neuropathic pain in a patient with multiple sclerosis treated successfully with topical amitriptyline","volume":"2012","author":"Kopsky","year":"2012","journal-title":"Case Rep Med"},{"key":"10.1111\/jcpt.12297-BIB0025|jcpt12297-cit-0025","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews","author":"Wiffen","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/jcpt.12297-BIB0026|jcpt12297-cit-0026","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/jcpt.12297-BIB0027|jcpt12297-cit-0027","article-title":"Antidepressants for neuropathic pain","author":"Saarto","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/jcpt.12297-BIB0028|jcpt12297-cit-0028","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults","author":"Moore","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/jcpt.12297-BIB0029|jcpt12297-cit-0029","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"32","author":"Hershman","year":"2014","journal-title":"J Clin Oncol"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12297","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12297","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12297\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:05:58Z","timestamp":1671818758000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,7]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12297","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6,7]]}}}